Showing results (1711-1720 of 2,458) with videos related to
Sort By:
Pageof 246
Therapie|December 21, 2020
Innovative approaches in CNS drug discoveryMathieu Charvériat, Vincent Lafon, Franck Mouthon, et al.Therapie|January 4, 2026
How to differentiate between clinical added value (CAV) V drugs: What are the implications, and what is the access pathway?Clémentine Body, Frédéric Chassagnol, Driss Berdaï, et al.Therapie|December 28, 2020
Experimental neuropsychopharmacology, yesterday, today and tomorrow. A conversation with Michel HamonMichel Hamon, Luc ZimmerTherapie|June 13, 2021
COVID-19 vaccines: A perspective from social pharmacologyJean-Louis Montastruc, Margaux Lafaurie, Claire de Canecaude, et al.Therapie|May 14, 2022
Comparative study of the adverse event profile of hydroxychloroquine before and during the Sars-CoV2 pandemicPauline Lory, Jeffrey Lombardi, Clémence Lacroix, et al.Therapie|September 1, 2019
The drugs that mostly frequently induce gynecomastia: A national case - noncase studyBenjamin Batteux, Benoît Llopis, Charlotte Muller, et al.Therapie|September 1, 2019
[The general practitioner's knowledge and attitude towards proton pump inhibitors adverse effects]Karen Rudelle, Marie-Laure LarocheTherapie|February 8, 2021
[Therapeutic drug monitoring of antidepressants: Why venlafaxine is the most monitored drug? A review of literature]Sylvain Couderc, Celine Mory, Léa Darnaud, et al.Therapie|October 25, 2016
[Which psychoactives substances are found in used syringes?]Sandra Nordmann, Thomas Nefau, Joëlle Micallef, et al.Pageof 246